Your Journey
Cancer Types
Advocacy Partner News
Conferences
INFORMATION BY CANCER TYPE
Liver
Overall survival (OS) was improved when patients with advanced liver cancer took Cabometyx (cabozantinib), compared to those who were given placebo. All participants previously took Nexavar (sorafenib).
After nearly a decade with no new therapies, new drugs to treat liver cancer are showing great promise, according to Steven R. Alberts, M.D.
Opdivo (nivolumab) was granted FDA approval for the treatment of hepatocellular carcinoma (HCC) – regardless of PD-L1 status – for patients who have previously been treated with Nexavar (sorafenib).
Andrea J. Wilson, president and founder of Blue Faery: The Adrienne Wilson Liver Cancer Association, offers advice for patients with liver cancer. Wilson started the foundation after her younger sister, Adrienne, died of liver cancer.
Opdivo (nivolumab) was granted a priority review designation by the Food and Drug Administration (FDA) to treat some patients with liver cancer.
The Food and Drug Administration (FDA) has approved Stivarga as a second-line treatment for patients with unresectable hepatocellular carcinoma (HCC) who have previously received Nexavar.
Understanding liver cancer is a crucial step toward the prevention of this rare condition.
Liver cancer diagnoses and mortality have been rising, but new treatments are designed to help reverse the trend.
A recent phase 3 trial showed that treatment with Lenvima is noninferior to standard treatment for patients with unresectable liver cancer.
Special Feature
Talk about this article with other patients, caregivers, and advocates in the Liver CURE discussion group.
Search Cancer Drugs & Terms
Treatment
Information about treatment, including surgery, chemotherapy, radiation therapy, immunotherapy, and vaccine therapy
Adult Primary Liver Cancer Treatment (PDQ®)
[ Patients ]
Expert-reviewed information summary about the treatment of adult primary liver cancer.
Childhood Liver Cancer Treatment (PDQ®)
[ Patients ]
Expert-reviewed information summary about the treatment of childhood liver cancer.
Prevention, Genetics, Causes
Information related to prevention, genetics, risk factors
Liver (Hepatocellular) Cancer Prevention (PDQ®)
[ Patients ]
Expert-reviewed information summary about factors that may influence the risk of developing hepatocellular cancer and about research aimed at the prevention of this disease.
Liver (Hepatocellular) Cancer Prevention (PDQ®)
Expert-reviewed information summary about factors that may influence the risk of developing hepatocellular cancer and about research aimed at the prevention of this disease.
Screening and Testing
Information about methods of cancer detection including new imaging technologies, tumor markers, and biopsy procedures
Liver (Hepatocellular) Cancer Screening (PDQ®)
[ Patients ]
Expert-reviewed information summary about tests used to detect or screen for liver (hepatocellular) cancer.
